[Toxoplasmosis. 2: Therapy and prevention].
Janitschke
K
K
Robert Koch-Institut, Konsiliarlaboratorium Toxoplasma, Berlin.
D003049:Coccidiostats / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011247:Pregnancy; D012307:Risk Factors; D014123:Toxoplasmosis / Q000188:drug therapy* / Q000635:transmission; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy / Q000635:transmission
D003049:Coccidiostats